doi:10.1056/NEJMoa1603827 98
It is a prevalent condition, impacting approximately 10% of women of reproductive age worldwideequating to around 190 million individualsand is highly associated with infertility, present in 3050% of women seeking infertility evaluation ( The pathophysiology involves complex interactions of endocrine, immunologic, and inflammatory processes, with retrograde menstruation as the most accepted theory for ectopic tissue implantation ( Clinical presentation is heterogeneous, encompassing menstruation-related pain (dysmenorrhea, dyspareunia), noncyclic pelvic pain, and infertility, with pain resulting from high densities of sensory nerve fibers in lesions and inflammatory processes ( Diagnosis remains challenging, often delayed by an average of 7 years from symptom onset, due to overlapping symptoms with other conditions and reliance on invasive laparoscopy with histological analysis as the gold standard ( 2 Pathophysiological mechanisms underlying infertility in endometriosis Endometriosis-associated infertility remains a complex and challenging clinical issue, with its underlying pathophysiological mechanisms being multi-faceted and interconnected
As you can imagine, it was very uncomfortable
Supplementary information 41366_2025_1859_MOESM4_ESM.docx (download DOCX Network meta-analysis summary for the assessed gastrointestinal adverse events associated with GLP-1 receptor agonists in subjects with overweight and obesity Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Massachusetts Blue Cross Blue Shield of Massachusetts, operating within the Anthem corporate family, ended obesity medication coverage effective January 1, 2026
